sulforaphane has been researched along with Acute Lung Injury in 5 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Acute Lung Injury: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulforaphane (SFN) is a phytochemical antioxidant known to affect multiple cellular targets including Nrf2-ARE pathway in chemoprevention." | 1.51 | Sulforaphane enriched transcriptome of lung mitochondrial energy metabolism and provided pulmonary injury protection via Nrf2 in mice. ( Bell, DA; Blankenship-Paris, T; Cho, HY; Deterding, L; Kleeberger, SR; Lih, F; Miller-DeGraff, L; Morgan, DL; Panduri, V; Reddy, AJ; Talalay, P; Wang, X; Yamamoto, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, L | 1 |
| Xu, L | 1 |
| Chen, H | 1 |
| Zhang, W | 1 |
| Xing, C | 1 |
| Qu, Z | 1 |
| Yu, J | 1 |
| Zhuang, C | 1 |
| Liang, W | 1 |
| Greven, J | 1 |
| Fragoulis, A | 1 |
| Horst, K | 1 |
| Bläsius, F | 1 |
| Wruck, C | 1 |
| Pufe, T | 1 |
| Kobbe, P | 1 |
| Hildebrand, F | 1 |
| Lichte, P | 1 |
| Cho, HY | 1 |
| Miller-DeGraff, L | 1 |
| Blankenship-Paris, T | 1 |
| Wang, X | 1 |
| Bell, DA | 1 |
| Lih, F | 1 |
| Deterding, L | 1 |
| Panduri, V | 1 |
| Morgan, DL | 1 |
| Yamamoto, M | 1 |
| Reddy, AJ | 1 |
| Talalay, P | 1 |
| Kleeberger, SR | 1 |
| Qi, T | 1 |
| Xu, F | 1 |
| Yan, X | 1 |
| Li, S | 1 |
| Li, H | 1 |
| Jensen, JS | 1 |
| Fan, X | 1 |
| Guidot, DM | 1 |
5 other studies available for sulforaphane and Acute Lung Injury
| Article | Year |
|---|---|
Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injury.
Topics: Acute Lung Injury; Animals; Dose-Response Relationship, Drug; Drug Design; Female; Kelch-Like ECH-As | 2021 |
Sulforaphane-Dependent Up-Regulation of NRF2 Activity Alleviates Both Systemic Inflammatory Response and Lung Injury After Hemorrhagic Shock/Resuscitation in Mice.
Topics: Acute Lung Injury; Animals; Isothiocyanates; Macrophages; Male; Mice; Mice, Inbred C57BL; NF-E2-Rela | 2022 |
Sulforaphane enriched transcriptome of lung mitochondrial energy metabolism and provided pulmonary injury protection via Nrf2 in mice.
Topics: Acute Lung Injury; Animals; Antioxidant Response Elements; Antioxidants; Disease Models, Animal; DNA | 2019 |
Sulforaphane exerts anti-inflammatory effects against lipopolysaccharide-induced acute lung injury in mice through the Nrf2/ARE pathway.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antioxidant Response Elements; Interleukin-6; | 2016 |
Alcohol causes alveolar epithelial oxidative stress by inhibiting the nuclear factor (erythroid-derived 2)-like 2-antioxidant response element signaling pathway.
Topics: Acute Lung Injury; Alcohol Drinking; Animals; Anticarcinogenic Agents; Blood-Air Barrier; Cell Line; | 2013 |